← Insider buys

TMO

Thermo Fisher Scientific Inc. · Healthcare

Insiders sold $133.0M of Thermo Fisher Scientific Inc. in the last 12 months and bought none

$0Bought, 12 mo
$133.0MSold, 12 mo
$243.3BMarket cap

TMO over the last year

No insider buys filed in this year

TMO after insider buys

3 months after each buy, from the first price a copier could get.

No buys have 3 months of prices yet. A record shows here at 3.

Congress

Members reported 103 trades in TMO since 2023.

Every filing

201 insider filings since 2016, newest first

TMOSell

Gianluca Pettiti · President and COO

$2.5M−15.1%Sep 1
TMOSell

Marc N Casper · Chair and CEO

$172K−0.2%Aug 26
TMOSell

Marc N Casper · Chair and CEO

$12.6M−13.9%Aug 24
TMOSell

Lisa P. Britt · Sr. VP and Chief HR Officer

$7.0M−43.6%Aug 20
TMOSell

Michael D Shafer · Executive Vice President

$15.3M−54.8%Aug 13
TMOSell

Joseph R. Holmes · VP and Chief Accounting Officer

$246K−12.4%Aug 10
TMOSell

Marc N Casper · Chair and CEO

$2.9M−100.0%Aug 10
TMOSell

Lisa P. Britt · Sr. VP and Chief HR Officer

$3.4M−28.4%Aug 7
TMOSell

Marc N Casper · Chair and CEO

$8.6M−76.5%Aug 7
TMOSell

Marc N Casper · Chair and CEO

$8.6M−61.0%Aug 7
TMOSell

Gianluca Pettiti · President and COO

$226K−1.6%Jul 28
TMOSell

Gianluca Pettiti · President and COO

$185K−2.0%Apr 29
TMOSell

Michael D Shafer · EVP

$803K−7.0%Mar 12
TMOSell

Marc N Casper · Chair and CEO

$2.1M−3.0%Mar 9
TMOSell

Marc N Casper · Chair and CEO

$5.1M−6.0%Mar 5
TMOSell

Gianluca Pettiti · EVP

$216K−2.0%Feb 11
TMOSell

Michel Lagarde · EVP and COO

$12.4M−21.0%Dec 5
TMOSell

Michel Lagarde · EVP and COO

$36.1M−49.0%Dec 4
TMOSell

Frederick M. Lowery · EVP

$8.2M−47.0%Dec 3
TMOSell

Michael D Shafer · EVP

$6.4M−36.0%Nov 26
TMOSell

Marc N Casper · Chair and CEO

$5.0M−6.0%Nov 12
TMOSell

Marc N Casper · Chair and CEO

$11.2M−11.0%Nov 8
TMOSell

Marc N Casper · Chair and CEO

$3.3M−3.0%Nov 4
TMOSell

Marc N Casper · Chair and CEO

$11.0M−10.0%Nov 1
TMOSell

Marc N Casper · Chair and CEO

$11.0M−10.0%Oct 30
TMOSell

Gianluca Pettiti · EVP

$168K−2.0%Oct 29
TMOSell

Michael A Boxer · SVP and General Counsel

$1.1M−14.0%Oct 29
TMOSell

Marc N Casper · Chair and CEO

$12.2M−10.0%Sep 5
TMOSell

Marc N Casper · Chair and CEO

$6.2M−5.0%Aug 1
TMOSell

Marc N Casper · Chair and CEO

$9.9M−8.0%Jul 31
TMOSell

Gianluca Pettiti · EVP

$180K−2.0%Jul 29
TMOSell

Joseph R. Holmes · VP and Chief Accounting Officer

$525K−32.0%Jul 29
TMOSell

Lisa P. Britt · SVP and CHRO

$2.2M−21.0%Jul 29
TMOSell

Michael A Boxer · SVP and General Counsel

$1.2M−13.0%Jul 29
TMOSell

Marc N Casper · Chair and CEO

$11.4M−10.0%Jun 5
TMOSell

Michel Lagarde · EVP and COO

$11.8M−52.0%May 15
TMOSell

Stephen Williamson · SVP and CFO

$13.0M−34.0%May 15
TMOSell

Marc N Casper · Chair and CEO

$5.7M−5.0%May 2
TMOSell

Marc N Casper · Chair and CEO

$11.5M−10.0%May 1
TMOSell

Michael A Boxer · SVP and General Counsel

$1.1M−13.0%Apr 29
TMOSell

Marc N Casper · Chair and CEO

$5.9M−5.0%Mar 14
TMOSell

Marc N Casper · Chair and CEO

$11.9M−10.0%Mar 13
TMOSell

Lisa P. Britt · SVP and CHRO

$8.6M−45.0%Mar 13
TMOSell

Marc N Casper · Chair and CEO

$5.7M−5.0%Mar 4
TMOSell

Marc N Casper · Chair and CEO

$11.3M−10.0%Feb 29
TMOSell

Marc N Casper · Chair and CEO

$3.1M−3.0%Feb 20
TMOSell

Debora L Spar · Director

$90K−12.0%Feb 14
TMOSell

Michael A Boxer · SVP and General Counsel

$8.2M−53.0%Feb 8
TMOSell

Marc N Casper · Chair and CEO

$5.6M−5.0%Feb 8
TMOSell

Marc N Casper · Chair and CEO

$5.3M−5.0%Nov 8
About Thermo Fisher Scientific Inc.

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services internationally. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Biopharma Services. The Life Sciences Solutions segment includes reagents, instruments, and consumables for biological and medical research; discovery and production of drugs and vaccines; and diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The Specialty Diagnostics segment offers clinical diagnostics products, such as liquid ready-to-use and lyophilized immunodiagnostic reagent kits, calibrators, controls, protein detection assays, and instruments; immunodiagnostic offerings comprising developing, manufacturing, and marketing of complete blood-test systems for the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; microbiology offerings, such as dehydrated and prepared culture media, collection and transport systems, instrumentation and consumables to detect pathogens in blood, diagnostic and rapid direct specimen tests, quality-control products, and associated products; transplant diagnostics products, including human leukocyte antigen typing and testing for the organ transplant market; and healthcare market channel offerings. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It has strategic collaboration with genedrive plc to develop a CYP2C19 pharmacogenetic in vitro diagnostic test. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.